U.S. Department of Labor 
Attachment IV - Page 13 
Occupational Safety and Health Administration 
Washington, D.C. 20210 
Reply to the Attention of: 
FEB 2 1 1985 
William J. Gartland, Jr., Ph.D. 
Director 
Office of Recombinant DNA Activities 
National Institutes of Health 
Building 31, Room 3B10 
Bethesda, Maryland 20205 
Dear Dr. Gartland: 
In accordance with your memorandum of January 22, 1985, the proposed document 
entitled "Points to Consider in the Design and Submission of Human Somatic-Cell Gene 
Therapy Protocols," has been reviewed and appears to be quite thorough. 
Thank you for the opportunity to review this important document. 
Sincerely, 
Director 
Directorate of Technical Support 
[ 40 ] 
